BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1668551)

  • 21. Ataxia caused by amiodarone in older people.
    Hindle JV; Ibrahim A; Ramaraj R
    Age Ageing; 2008 May; 37(3):347-8. PubMed ID: 18385185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amiodarone-induced epididymitis. Report of 2 cases.
    Hamoud K; Kaneti J; Smailowitz Z; Lissmer L
    Eur Urol; 1996; 29(4):497-8. PubMed ID: 8791063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Amiodaron neuropathy: drug-induced lipidosis (author's transl)].
    Dudognon P; Hauw JJ; de Baecque C; Escourolle R; Derrida JP; Nick J
    Nouv Presse Med; 1979 May; 8(21):1766-7. PubMed ID: 221884
    [No Abstract]   [Full Text] [Related]  

  • 24. Amiodarone and ischemic optic neuropathy.
    Younge BR
    J Neuroophthalmol; 2007 Mar; 27(1):85-6. PubMed ID: 17414882
    [No Abstract]   [Full Text] [Related]  

  • 25. Visual changes secondary to initiation of amiodarone: a case report and review involving ocular management in cardiac polypharmacy.
    Castells DD; Teitelbaum BA; Tresley DJ
    Optometry; 2002 Feb; 73(2):113-21. PubMed ID: 12365708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiodarone toxicity: recurrence of interstitial pneumonitis after withdrawal of the drug.
    Parra O; Ruiz J; Ojanguren I; Navas JJ; Morera J
    Eur Respir J; 1989 Oct; 2(9):905-7. PubMed ID: 2806517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
    Primeau R; Agha A; Giorgi C; Shenasa M; Nadeau R
    Can J Cardiol; 1989 Mar; 5(2):98-104. PubMed ID: 2706579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Amiodarone in the acute treatment of hyperkinetic arrhythmias in cardiosurgery].
    Vitale P; Agretto A; Torre G; Casale D; Porreca GP; Jacono A
    Cardiologia; 1983 May; 28(5):419-29. PubMed ID: 6687178
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ocular side-effects associated with amiodarone therapy].
    Turdumambetova G; Bredehorn T; Duncker GI
    Klin Monbl Augenheilkd; 2005 Jun; 222(6):485-92. PubMed ID: 15973627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Visual impairment due to optic neuropathy in 2 patients on amiodarone therapy, i.e. ethambutol and isoniazide].
    Polak BC; Tutein Nolthenius PA; Rietveld E
    Ned Tijdschr Geneeskd; 2001 May; 145(19):922-6. PubMed ID: 11387869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuropathy and cerebellar syndrome induced by amiodarone].
    Mizon JP; Rosa A; Betermiez P; Sevestre H
    Rev Neurol (Paris); 1985; 141(2):146-8. PubMed ID: 4001701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Amiodarone in the treatment of arrhythmias].
    Raatikainen MJ; Huikuri HV
    Duodecim; 1998; 114(19):1923-36. PubMed ID: 11717746
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thyroid functional parameters during anti-arrhythmia therapy with amiodarone].
    Weissel M; Weber H; Probst P; Höfer R
    Acta Med Austriaca; 1984; 11(3-4):113-7. PubMed ID: 6475471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Amiodarone in the treatment of cardiac arrhythmias].
    Moura A; Moura AV
    Arq Bras Cardiol; 1986 Mar; 46(3):165-9. PubMed ID: 3548662
    [No Abstract]   [Full Text] [Related]  

  • 35. [Amiodarone: the most effective and the most problematic arrhythmia drug].
    Toivonen L; Viitasalo M
    Duodecim; 1990; 106(20):1352-61. PubMed ID: 1670567
    [No Abstract]   [Full Text] [Related]  

  • 36. [Amiodarone therapy in childhood: efficacy and side effects].
    Vignati G; Danzi GB; Austoni P; Fancini P; Mascarello M; Figini A
    G Ital Cardiol; 1985 Aug; 15(8):786-94. PubMed ID: 2935440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Peripheral neuropathy and amiodarone].
    Schwartz Calero P; Torelló Iserte J; Giner Calzada E; Cuder Ambel A
    Aten Primaria; 2000 Apr; 25(6):450-2. PubMed ID: 10857240
    [No Abstract]   [Full Text] [Related]  

  • 38. [Amiodarone as an anti-arrhythmia agent].
    Giec L
    Kardiol Pol; 1985; 28(1):1-9. PubMed ID: 4010140
    [No Abstract]   [Full Text] [Related]  

  • 39. Amiodarone for cardiac arrhythmias. Key management issues for NPs.
    McLemore R
    Adv Nurse Pract; 2001 Apr; 9(4):69-71. PubMed ID: 12420439
    [No Abstract]   [Full Text] [Related]  

  • 40. Rationale, development, and clinical outcomes of a multidisciplinary amiodarone clinic.
    Sanoski CA; Schoen MD; Gonzalez RC; Avitall B; Bauman JL
    Pharmacotherapy; 1998; 18(6 Pt 2):146S-151S. PubMed ID: 9855347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.